Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Takeda Pharmaceutical Co Ltd (JP:4502)
TSE/TYO:4502
Holding JP:4502?
Track your performance easily
4502 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥3,852.00 - ¥4,494.00
Previous Close¥4,121
Volume3.98M
Average Volume (3M)3.78M
Market Cap
¥6.53T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)22.4
Beta0.51
Next Earnings
Jan 30, 2025EPS Estimate
¥32.82Next Dividend Ex-Date
Mar 28, 2025Dividend Yield4.81%
Share Statistics
EPS (TTM)184.31
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume3,780,078
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥4,669.78Price Target Upside13.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Takeda Pharmaceutical Co News
PremiumCompany Announcements
Takeda Pharmaceutical Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Takeda Reports Impressive Profit Growth Amid Revenue RiseOptions Prices
Currently, No data available
---
Ownership Overview
― Insiders
7.55% Mutual Funds
<0.01% Other Institutional Investors
83.55% Public Companies and
Individual Investors
4502 FAQ
What was Takeda Pharmaceutical Co Ltd’s price range in the past 12 months?
Takeda Pharmaceutical Co Ltd lowest stock price was ¥3852.00 and its highest was ¥4494.00 in the past 12 months.
What is Takeda Pharmaceutical Co Ltd’s market cap?
Currently, no data Available
When is Takeda Pharmaceutical Co Ltd’s upcoming earnings report date?
Takeda Pharmaceutical Co Ltd’s upcoming earnings report date is Jan 30, 2025 which is in 69 days.
How were Takeda Pharmaceutical Co Ltd’s earnings last quarter?
Takeda Pharmaceutical Co Ltd released its earnings results on Oct 31, 2024. The company reported ¥58.21 earnings per share for the quarter, beating the consensus estimate of ¥37.045 by ¥21.165.
Is Takeda Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Takeda Pharmaceutical Co Ltd’s price is currently Undervalued.
Does Takeda Pharmaceutical Co Ltd pay dividends?
Takeda Pharmaceutical Co Ltd pays a Annually dividend of ¥98 which represents an annual dividend yield of 4.81%. See more information on Takeda Pharmaceutical Co Ltd dividends here
What is Takeda Pharmaceutical Co Ltd’s EPS estimate?
Takeda Pharmaceutical Co Ltd’s EPS estimate is ¥32.82.
How many shares outstanding does Takeda Pharmaceutical Co Ltd have?
Takeda Pharmaceutical Co Ltd has 1,590,937,600 shares outstanding.
What happened to Takeda Pharmaceutical Co Ltd’s price movement after its last earnings report?
Takeda Pharmaceutical Co Ltd reported an EPS of ¥58.21 in its last earnings report, beating expectations of ¥37.045. Following the earnings report the stock price went up 0.306%.
Which hedge fund is a major shareholder of Takeda Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in JP:4502
---
Takeda Pharmaceutical Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
¥4,669.78 (13.32% Upside)
¥4,669.78 (13.32% Upside)
Insider Transactions
Sold Shares
Worth $284.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.31%
12-Months-Change
Fundamentals
Return on Equity
4.02%
Trailing 12-Months
Asset Growth
2.23%
Trailing 12-Months
Company Description
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
---
4502 Company Deck
---
4502 Earnings Call
Q2 2024
0:00 / 0:00
---
4502 Stock 12 Month Forecast
Average Price Target
¥4,669.78
▲(13.32% Upside)
Technical Analysis
Best Analysts Covering 4502
1 Year
---